Influence of imipramine treatment on the group I of metabotropic glutamate receptors in CA1 region of hippocampus

Polish Journal of Pharmacology

Volumn 49, Issue 6, 1997, Pages 495-497

  Pałucha, Agnieszka ^a   Brański, Piotr ^a   Tokarski, Krzysztof ^a   Bijak, Maria ^a   Pilc, Andrzej ^a  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

Author keywords

(S1S,3R) 1 carboxycyclopentane 3 acetic acid (1S,3R ACPD); Hippocampus; Imipramine; Inositol phosphates; Metabotropic glutamate receptors

Indexed keywords

1 CARBOXYCYCLOPENTANE 3 ACETIC ACID; GLUTAMATE RECEPTOR AGONIST; IMIPRAMINE; INOSITOL PHOSPHATE; METABOTROPIC RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL TISSUE; BRAIN SLICE; CONTROLLED STUDY; DRUG EFFECT; HIPPOCAMPUS; NERVE CONDUCTION; NONHUMAN; RAT; RECEPTOR SENSITIVITY; SHORT SURVEY; SIGNAL TRANSDUCTION;

ANIMALS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; CYCLOLEUCINE; ELECTROPHYSIOLOGY; EXCITATORY AMINO ACID AGONISTS; HIPPOCAMPUS; IMIPRAMINE; INOSITOL PHOSPHATES; MALE; RATS; RATS, WISTAR; RECEPTORS, METABOTROPIC GLUTAMATE;

EID: 2642706691     PISSN: 12306002     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (10)

1. Conn P. J., Pin J. P.: Pharmacology and functions of metabotropic glutamate receptors. Annu. Rev. Pharmacol. Toxicol., 1997, 37, 205-237.
2. Davies C. H., Clarke V. R. J., Jane D. E., Collingridge G. L.: Pharmacology of postsynaptic metabotropic glutamate receptors in rat hippocampal CA1 pyramidal neurones. Brit. J. Pharmacol., 1995, 116, 1859-1869.
3. Gereau R. W., Conn P. J.: Roles of specific metabotropic glutamate receptor subtypes in regulation of hippocampal CA1 pyramidal cell excitability. J. Neurophysiol., 1995, 74, 122-129.
4. Kendall D. A., Hill S. J.: Measurement of (3H) inositol phospholipid turnover. In: Methods in Neurotransmitter Receptor Analysis. Eds. Yamamaura H. I., Enna S. J., Kuhar M. J., Raven Press, New York, 1990, 69-87.
5. Lesch K. P., Aulakh C. S., Wolozin B. L., Murphy D. L.: Serotonin (5-HT) receptor, 5-HT transporter and G protein-effector expression: implications for depression. Pharmacol. Toxicol., 1992, 71, Suppl 1, 49-60.
6. Mann C. D., Vu T. B., Hrdina P. D.: Protein kinase C in rat brain cortex and hippocampus: effect of repeated administration of fluoxetine and desipramine. Brit. J. Pharmacol., 1995, 115, 595-600.
7. Pilc A., Legutko B.: The influence of prolonged antidepressant treatment on the changes in cyclic AMP accumulation induced by excitatory amino acids in rat cerebral cortical slices. NeuroReport, 1995, 7, 85-88.
8. Pilc A., Legutko B.: Antidepressant treatment influences cyclic AMP accumulation induced by excitatory amino acids in rat brain. Pol. J. Pharmacol., 1995, 47, 359-361.
9. Pin J. P., Duvoisin R.: The metabotropic glutamate receptors: structure and functions. Neuropharmacology, 1995, 34, 1-26.
10. Skolnick P., Layer R. T., Popik P., Nowak G., Paul I. A., Trullas R.: Adaptation of N-methyl-D-aspartate (NMDA) receptors following antidepressant treatment: implications for the pharmacotherapy of depression. Pharmacopsychiatry, 1996, 29, 23-26.